Connect Biopharma Limite...

NASDAQ: CNTB · Real-Time Price · USD
2.03
-0.12 (-5.58%)
At close: Aug 15, 2025, 3:59 PM
2.09
2.96%
After-hours: Aug 15, 2025, 05:23 PM EDT

Connect Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
1.91M 24.12M n/a n/a n/a n/a n/a n/a
Cost of Revenue
183.53K n/a 481.87K 506.13K 527.3K 503.34K 412.05K 221.39K
Gross Profit
1.73M 23.64M -481.87K -506.13K -527.3K -503.34K -412.05K -221.39K
Operating Income
-24.91M 7.31M -27.23M -34.84M -54.28M -63.38M -58.26M -41.09M
Interest Income
4.03M 822K -2.49M 2.49M 1.29M 271.1K 54.89 22.92
Pretax Income
-23.05M 7.71M -28.87M -30.52M -56.49M -59.63M -56.39M -145.71M
Net Income
-23.22M 7.65M -28.92M -30.58M -56.68M -59.74M -56.65M -145.71M
Selling & General & Admin
11.8M 7.43M 5.92M 7.61M 9.16M 11.21M 11.17M 7.19M
Research & Development
15.9M 13.32M 25.18M 26.73M 44.6M 50.66M 46.68M 33.67M
Other Expenses
-1.07M -3.94M -4.35M n/a n/a -940.31K n/a n/a
Operating Expenses
26.63M 16.81M 27.74M 34.34M 53.76M 60.93M 57.85M 40.87M
Interest Expense
-20K 20K -10.39K 10.39K 12.32K 8.72K n/a n/a
Selling & Marketing Expenses
n/a n/a 5.94M 7.58M 9.12M -9.12M 11.16M 7.19M
Cost & Expenses
26.82M 16.81M 27.23M 34.84M 54.28M 60.4M 58.26M 41.09M
Income Tax Expense
162.58K 60K 55.22K 64.78K 186.17K 111.34K 263.87K n/a
Shares Outstanding (Basic)
55.19M 55.14M 55.07M 55.05M 55.02M 55.02M 53.74M 46.94M
Shares Outstanding (Diluted)
55.19M 55.55M 55.07M 55.05M 55.02M 55.02M 53.74M 46.94M
EPS (Basic)
-0.42 0.14 -0.52 -0.56 -1.03 -13.47 -1.05 -3.1
EPS (Diluted)
-0.42 0.14 -0.52 -0.56 -1.03 -13.47 -1.05 -3.1
EBITDA
-22.87M 8.2M -28.37M -30M -53.76M -57.55M -57.85M -40.87M
EBIT
-23.05M 7.72M -28.85M -30.51M -56.48M -61.56M -56.39M -20.58M
Depreciation & Amortization
183.53K 476K 481.87K 506.13K 527.3K 486.34K 412.05K 221.39K